Moderna

Business

Can Moderna stock rebound in 2024? (NASDAQ:MRNA)

Maddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) was among the leading healthcare decliners in 2023 as demand for its COVID-19 vaccine…

Read More »
Back to top button